☆ 4.6 Article

Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Urology & Nephrology

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

Maxime Espi et al.

Summary: The level of protection provided by two doses of COVID-19 mRNA vaccines in patients receiving maintenance hemodialysis (MHD) is uncertain. This study found that vaccination significantly reduced the incidence and severity of COVID-19, but 11% of patients infected after two doses still died. Lack of protection in SARS-CoV-2-naive patients could be due to defective T-cell response and failure to generate sufficient neutralizing antibodies after vaccination. Administering a third dose of vaccine improved protection in low/no responders. High responders did not show an increase in antibodies after the third dose but experienced more side effects. The antibody and T-cell response after two doses can guide personalized administration of the third dose in MHD patients.

KIDNEY INTERNATIONAL (2022)

添加到收藏夹

Article Urology & Nephrology

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

Ilias Bensouna et al.

Summary: The effectiveness of a third dose of the BNT162b2 vaccine in patients undergoing dialysis treatment was investigated, and it was found that the third dose significantly increased antibody levels.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

添加到收藏夹

Article Urology & Nephrology

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

Jose Jesus Broseta et al.

Summary: This study evaluated the humoral and cellular responses to mRNA SARS-CoV-2 vaccines in patients with kidney failure receiving maintenance dialysis. Results showed that a high proportion of patients developed humoral and cellular immune responses after vaccination, but older age and immunosuppressive treatment were associated with lower antibody levels.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

添加到收藏夹

Article Immunology

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Agnes Bonifacius et al.

Summary: Research showed that active COVID-19 patients had high levels of anti-SARS-CoV-2 nucleocapsid and spike IgG, but overall reduced antiviral T cell responses due to inflammatory environment, expression of inhibitory molecules, and effector caspase activity in T cells.

IMMUNITY (2021)

添加到收藏夹

Article Microbiology

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

Sean C. Taylor et al.

Summary: The cPass surrogate virus neutralization test (sVNT) is a highly accurate tool for monitoring SARS-CoV-2 immunity, providing valuable assistance in surveillance of infected/recovered and/or vaccinated individuals, as well as in drug and convalescent-phase donor screening. The data also suggest potential applications for calibrating live-cell neutralization tests and longitudinal testing of recovered and/or vaccinated patients.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis

Shuchi Anand et al.

Summary: Assessing the evolution of SARS-CoV-2 immune response among patients receiving dialysis showed that most seropositive patients maintained RBD antibody levels over 6 months, with a slow and continual decline in median antibody levels over time. No indication was found that subgroups with impaired immunity had a shorter-lived humoral response.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Urology & Nephrology

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

Ayelet Grupper et al.

Summary: Patients on maintenance hemodialysis showed a significantly lower humoral response following the BNT162b2 vaccine compared to the control group, with age being an important factor in the humoral response.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Emelissa J. Valcourt et al.

Summary: The study evaluated the sensitivity, specificity, and cross-reactivity of sVNT compared with PRNT for SARS-CoV-2 neutralizing antibodies, finding sVNT to be a high-throughput screening tool for evaluation prior to confirmatory PRNT testing.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies

Niko Kohmer et al.

Summary: The PRNT and alternative detection methods show differences in clinical performance and laboratory safety conditions, with high sensitivity and specificity for clinical samples.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Urology & Nephrology

Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2

Claudius Speer et al.

Summary: Patients receiving long-term hemodialysis show a reduced antibody response to the first and second doses of the mRNA vaccine BNT162b2. The majority (82%) develop neutralizing antibodies after the second dose but at lower levels than healthy controls.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Virology

Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay

Katarina Resman Rus et al.

Summary: The study compared Elecsys Anti-SARS-CoV-2 S (Elecsys-S) with neutralization tests (NT) for detecting and quantifying anti-SARS-CoV-2 neutralizing antibodies (NAb). Elecsys-S showed a high detection rate of pan-anti-S1-RBD-SARS-CoV-2 antibodies and moderate agreement with NT results.

JOURNAL OF CLINICAL VIROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

Clement Danthu et al.

Summary: The study shows that kidney transplant recipients have a strong inhibition of humoral response to COVID-19 vaccination due to immunosuppressant therapy, while patients undergoing hemodialysis have lower antibody levels. Factors such as age, serum albumin, and Kt/V can impact the level of antibody response.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Biochemical Research Methods

Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2

Katharina Mueller et al.

Summary: In this study, commercial sELISA kits from GenScript and AdipoGen were investigated for the detection of SARS-CoV-2 neutralising antibodies (NAbs). The GenScript ELISA showed superior sensitivity, while the AdipoGen ELISA exhibited higher specificity. Both sELISA were able to qualitatively detect NAbs in plasma samples but were unable to quantify. AdipoGen could potentially serve as a confirmatory test with high specificity in a two-step diagnostic algorithm.

JOURNAL OF VIROLOGICAL METHODS (2021)

添加到收藏夹

Letter Urology & Nephrology

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis

Didier Ducloux et al.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Zijun Wang et al.

Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.

NATURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk et al.

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

添加到收藏夹

Article Immunology

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

Eva Schrezenmeier et al.

Summary: The study found that patients on chronic dialysis may have impaired immunogenicity to SARS-CoV-2 vaccines, but exhibit a strong immune response three to four weeks after the second dose. However, their seroconversion rates and antibody titers were lower compared to a cohort of vaccinees of similar age, indicating the need for further attention and research in this vulnerable group.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Microbiology

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays

Thomas Perkmann et al.

Summary: Reliable quantification of the antibody response to SARS-CoV-2 is crucial for identifying possible vaccine failure and estimating protection time. Despite good overall agreement, the performance of five antibody quantification assays showed differences that highlight the need for further standardization of SARS-CoV-2 serology.

MICROBIOLOGY SPECTRUM (2021)

添加到收藏夹

Article Infectious Diseases

In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients

Raquel Rubio-Acero et al.

Summary: This study found that two quantitative anti-S1 assays, EI-S1-IgG-quant and Ro-RBD-Ig-quant, showed good correlation and could replace direct neutralization assays for measuring immune protection against SARS-CoV-2. Antibody titers decreased over time, but a higher proportion of positive values remained with Ro-RBD-Ig-quant after 240 days.

INFECTIOUS DISEASES AND THERAPY (2021)

添加到收藏夹

Article Transplantation

COVID-19 vaccination in haemodialysis patients: good things come in threes...

Luc Frantzen et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

添加到收藏夹

Article Cell Biology

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

Kristen W. Cohen et al.

Summary: The study reveals that COVID-19 patients have durable broad-based immune responses, including the continuous generation of antibodies, memory B cells, and polyfunctional T cells, which help to rapidly generate antibody responses against virus re-exposure or vaccination.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Editorial Material Urology & Nephrology

The Novel Coronavirus 2019 epidemic and kidneys

Saraladevi Naicker et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Article Urology & Nephrology

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Kitty J. Jager et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Article Urology & Nephrology

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

Olivier Thaunat et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Review Urology & Nephrology

Current Knowledge of Vaccinations in Chronic Kidney Disease Patients

Intissar Haddiya

INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2020)

添加到收藏夹

Review Urology & Nephrology

Disturbances of acquired immunity in hemodialysis patients

Theodoros Eleftheriadis et al.

SEMINARS IN DIALYSIS (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.